IndustryCompany release

Grown Rogue posts $11.0M Q3 revenue, books $8.9M net loss on Illinois deal

🇺🇸 Grown Rogue International Inc. (GRUSF) · Fri 13 Nov 2026

The cannabis operator's Q3 2026 loss stems from a $5.0M charge on acquiring Rogue EBC, while it holds guidance and awaits approvals for a New York deal.

Grown Rogue International (CSE: GRIN) reported third-quarter 2026 results on 12 November, showing revenue of $11.0M and Adjusted EBITDA of $2.6M. The headline GAAP result was an $8.9M net loss.

The company attributed a large part of that loss to a $5.0M charge on its acquisition of Rogue EBC, a transaction linked to its entry into the Illinois market.

Grown Rogue kept its guidance for 2026 and 2027 unchanged. The guidance does not include New York.

It also gave updates on cultivation in Minnesota and on its planned purchase of PharmaCann's New York licence and assets. That acquisition still depends on regulatory approvals, and the company has not completed it. The summary available does not give further detail on timing or on the Minnesota update.

What it means for your team

  • The gap between positive Adjusted EBITDA and the GAAP net loss shows how one-off acquisition charges can dominate reported results in a state-by-state expansion.
  • The PharmaCann New York acquisition remains subject to regulatory approvals, so licence transfers are a gating item and the deal is excluded from guidance.
  • Teams tracking US state-licensed cannabis operators should note the company's expansion footprint now spans Illinois, Minnesota and a pending New York position.

Company's press release (SEC filing): Grown Rogue International Inc. ↗

Article written by VigiEye from the official source (Grown Rogue International Inc.). Claims are the company's own. AI-assisted; check the source before acting.

More Industry All →